Lessons learned from use of highly active antiretroviral therapy in Africa.
about
Economic and quality of life outcomes of antiretroviral therapy for HIV/AIDS in developing countries: a systematic literature reviewCost, affordability and cost-effectiveness of strategies to control tuberculosis in countries with high HIV prevalence.Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisalThe increasing chronicity of HIV in sub-Saharan Africa: Re-thinking "HIV as a long-wave event" in the era of widespread access to ARTThe challenge of HIV-1 antiretroviral resistance in Africa in the era of HAART.Lessons learned from family-centred models of treatment for children living with HIV: current approaches and future directionsPreliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South AfricaGender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic review.HIV treatment in a conflict setting: outcomes and experiences from Bukavu, Democratic Republic of the CongoHow far will we need to go to reach HIV-infected people in rural South Africa?Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic reviewGood adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: the experience of The AIDS Support Organization (TASO), Kampala, Uganda.Universal access: the benefits and challenges in bringing integrated HIV care to isolated and conflict affected populations in the Republic of Congo.Voices on adherence to ART in Ethiopia and Uganda: a matter of choice or simply not an option?Antiretroviral therapy, labor productivity, and sex: a longitudinal cohort study of tea pluckers in Kenya.Safety and efficacy of initiating highly active antiretroviral therapy in an integrated antenatal and HIV clinic in Johannesburg, South Africa.Risk of deaths, AIDS-defining and non-AIDS defining events among Ghanaians on long-term combination antiretroviral therapy.Women experience a better long-term immune recovery and a better survival on HAART in Lao People's Democratic Republic.Simplified Assessment of Antiretroviral Adherence and Prediction of Virological Efficacy in HIV-Infected Patients in CambodiaResponse to zidovudine/didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical trial.A cost-effectiveness analysis of alternative HIV retesting strategies in sub-saharan AfricaRenal and metabolic toxicities following initiation of HIV-1 treatment regimen in a diverse, multinational setting: a focused safety analysis of ACTG PEARLS (A5175).The Day-Hospital of the University Hospital, Bobo Dioulasso: An Example of Optimized HIV Management in Southern Burkina FasoHearing Loss in HIV-Infected Children in Lilongwe, Malawi.Assessment of quality of life in HAART-treated HIV-positive subjects with body fat redistribution in Rwanda.Community-based ART distribution system can effectively facilitate long-term program retention and low-rates of death and virologic failure in rural Uganda.Increased Rates of Respiratory and Diarrheal Illnesses in HIV-Negative Persons Living With HIV-Infected Individuals in a Densely Populated Urban Slum in Kenya.HIV treatment and care in resource-constrained environments: challenges for the next decade.Adherence to antiretroviral therapy and treatment outcomes among conflict-affected and forcibly displaced populations: a systematic review.Evidence base for using corticosteroids to treat HIV-associated immune reconstitution syndrome.Gender differences in mortality and CD4 count response among virally suppressed HIV-positive patients.Scaling up antiretroviral therapy in South Africa: the impact of speed on survival.The impact of HIV treatment on risk behaviour in developing countries: a systematic review.Two-year virologic outcomes of an alternative AIDS care model: evaluation of a peer health worker and nurse-staffed community-based program in UgandaSteep declines in population-level AIDS mortality following the introduction of antiretroviral therapy in Addis Ababa, Ethiopia.Rapid decline in the efficiency of HIV drug resistance genotyping from dried blood spots (DBS) and dried plasma spots (DPS) stored at 37 degrees C and high humidity.The impacts of first line highly active antiretroviral therapy on serum selenium, CD4 count and body mass index: a cross sectional and short prospective studyCost-effectiveness of anti-retroviral therapy at a district hospital in southern Ethiopia.CD4+ response and subsequent risk of death among patients on antiretroviral therapy in Lusaka, Zambia.Adult combination antiretroviral therapy in sub-Saharan Africa: lessons from Botswana and future challenges.
P2860
Q22248034-F868E5BA-C14B-48AF-B905-1C4A8B2283A7Q25255728-11AC52B0-6A6A-48FF-A878-0A51F803A5CBQ28476337-EE0EE453-36FF-4250-A542-6DA0F12207D3Q30408451-536E8D0C-AFC0-411D-9EB5-A80C07276AC9Q30425595-C85E9164-38E9-40B0-8C5F-03AE3EEBBEF7Q30495089-E098AF1E-636B-4751-8EEF-5F5F7F6F4B59Q33279183-83023BFE-A98C-4631-B201-E5D30F2EC3C9Q33282786-756B68E7-CC49-4336-BF9A-D428B05CBBFCQ33286063-C17592F9-EFB4-44D1-911E-8C6DC3C9153BQ33288122-3A9ECAB7-23D4-4F5A-9CC9-69BAE5CC95F5Q33302944-EE39C2DB-7687-4638-BD8D-12184221ECDAQ33385849-00BEEB38-F0B0-43C9-84BF-19CD9D86A394Q33397869-FACD003C-6079-4A98-95D5-7A60D6DB4F26Q33520008-E759B79A-AE68-4F32-AB9E-1AE1AFE615CAQ33831891-481ECA41-828B-47E0-90FB-33040E89149DQ33944686-19081D2C-A850-43DB-8E5D-4B6214F60F2FQ34395892-0798D00A-9FAC-476E-98F6-0B2DB6236B07Q34556999-2139840D-409E-4C46-A045-28811E0C60B6Q34730386-816FF747-54CF-484C-B444-05064F958FD9Q34732899-492342E4-A23A-4911-99C8-544B9832AE33Q35126864-03D69F5E-A44F-4436-BA0E-D69DB46E7EDEQ35170350-997060AC-B2CE-4EEB-AA30-34546A2C2D58Q35601898-3161DA51-074C-4881-B5AF-E74EC1342AD4Q36110248-B763D7CA-E687-4D3F-A69E-577ABA3B788DQ36138069-D3EC99E5-C814-4235-96F7-6B7A3506568EQ36273986-D260714B-DCF4-4D8A-95E1-A28E5BCCAE91Q36331265-CB98DC11-7E06-4307-B116-C60C42404ECCQ36386806-C6677EB8-AE97-46F7-B2E4-82C75197851EQ36498538-D7290CC0-3471-43BC-BDD5-4FF6AAF8FDDEQ36505513-CB2A5D7B-8F1B-49D4-A7A4-902DD3B477DFQ36629441-519257BD-6E66-4F68-B82D-B79A70F1E83FQ36711798-EEA3E9F7-9559-4F42-B7C9-08487C93D2A9Q36851070-90168D03-D3FF-4B9D-8790-20C69415141FQ37143605-8FC2D0A7-855D-473D-916B-D1CBAF1B3B0BQ37153607-3D11F587-2C4E-4BE0-AF0A-D887DB40ED14Q37217095-BD3639F5-9AC9-426A-9A4F-D68F800538BDQ37260327-6A6FF87E-9145-428B-95A9-D9F33A6DD9E4Q37299154-737787B6-0220-46A4-9743-13B1AEEC73A1Q37325907-E1216B9F-CF10-4DCA-9B19-A9B5884D888FQ37415603-F47A5E96-C827-4A7B-99B5-F8EC58A4EFFD
P2860
Lessons learned from use of highly active antiretroviral therapy in Africa.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Lessons learned from use of highly active antiretroviral therapy in Africa.
@ast
Lessons learned from use of highly active antiretroviral therapy in Africa.
@en
type
label
Lessons learned from use of highly active antiretroviral therapy in Africa.
@ast
Lessons learned from use of highly active antiretroviral therapy in Africa.
@en
prefLabel
Lessons learned from use of highly active antiretroviral therapy in Africa.
@ast
Lessons learned from use of highly active antiretroviral therapy in Africa.
@en
P356
P1476
Lessons learned from use of highly active antiretroviral therapy in Africa.
@en
P2093
Chitra Akileswaran
Timothy P Flanigan
P304
P356
10.1086/431482
P407
P577
2005-06-30T00:00:00Z